EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms

EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms

Moon Jung Choi,1 Kang Chan Choi,1 Do Hyun Lee,1 Hwa Yeon Jeong,1 Seong Jae Kang,1 Min Woo Kim,1 In Ho Jeong,1 Young Myoung You,1 Jin Suk Lee,2 Yeon Kyung Lee,1 Chan Su Im,1 Yong Serk Park1 1Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea; 2Department of Anato...

Full description

Bibliographic Details
Main Authors: Choi MJ, Choi KC, Lee DH, Jeong HY, Kang SJ, Kim MW, Jeong IH, You YM, Lee JS, Lee YK, Im CS, Park YS
Format: Article
Language:English
Published: Dove Medical Press 2022-07-01
Series:Nanotechnology, Science and Applications
Subjects:
cell-derived nanoparticles
immune surveillance
cd47
doxorubicin
tumor targeting
cancer therapy
Online Access:https://www.dovepress.com/egf-receptor-targeting-cancer-therapy-using-cd47-engineered-cell-deriv-peer-reviewed-fulltext-article-NSA

Internet

https://www.dovepress.com/egf-receptor-targeting-cancer-therapy-using-cd47-engineered-cell-deriv-peer-reviewed-fulltext-article-NSA

Similar Items